IL159770A0 - Calcium salts with cytotoxic activity - Google Patents

Calcium salts with cytotoxic activity

Info

Publication number
IL159770A0
IL159770A0 IL15977002A IL15977002A IL159770A0 IL 159770 A0 IL159770 A0 IL 159770A0 IL 15977002 A IL15977002 A IL 15977002A IL 15977002 A IL15977002 A IL 15977002A IL 159770 A0 IL159770 A0 IL 159770A0
Authority
IL
Israel
Prior art keywords
calcium salts
medicaments
cytotoxic activity
tumor
administered
Prior art date
Application number
IL15977002A
Other languages
English (en)
Original Assignee
Bilton Consultadoria E Marketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bilton Consultadoria E Marketi filed Critical Bilton Consultadoria E Marketi
Publication of IL159770A0 publication Critical patent/IL159770A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/16—Fluorine compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL15977002A 2001-07-12 2002-07-01 Calcium salts with cytotoxic activity IL159770A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001MI001495A ITMI20011495A1 (it) 2001-07-12 2001-07-12 Sali di calcio ad attivita' citotossica
PCT/EP2002/007222 WO2003006031A1 (en) 2001-07-12 2002-07-01 Calcium salts with cytotoxic activity

Publications (1)

Publication Number Publication Date
IL159770A0 true IL159770A0 (en) 2004-06-20

Family

ID=11448051

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15977002A IL159770A0 (en) 2001-07-12 2002-07-01 Calcium salts with cytotoxic activity
IL159770A IL159770A (en) 2001-07-12 2004-01-08 Pharmaceutical preparations containing calcium trifluoroacetate with cytotoxic activity

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL159770A IL159770A (en) 2001-07-12 2004-01-08 Pharmaceutical preparations containing calcium trifluoroacetate with cytotoxic activity

Country Status (10)

Country Link
US (1) US7423063B2 (ja)
EP (1) EP1423131B1 (ja)
JP (1) JP4395368B2 (ja)
AT (1) ATE345805T1 (ja)
CA (1) CA2455710C (ja)
DE (1) DE60216292T2 (ja)
ES (1) ES2277620T3 (ja)
IL (2) IL159770A0 (ja)
IT (1) ITMI20011495A1 (ja)
WO (1) WO2003006031A1 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20040665A1 (it) * 2004-04-02 2004-07-02 Pharmaproducts Uk Ltd Sale di calcio per il trattamento della psoriasi e di dermatiti
ITMI20041279A1 (it) * 2004-06-24 2004-09-24 Pharmaproducts Uk Ltd Uso di calcio trifluoroacetato per la preparazione di medicamenti ad effetto anti-angiogenetico
ITMI20041822A1 (it) * 2004-09-24 2004-12-24 Pharmaproducts Uk Ltd "agente terapeutico utile per il trattamento di neoplasie plasmacellulari"
EP2796135A1 (en) 2013-04-22 2014-10-29 Polichem S.A. Use of trifluoroacetic acid and salts thereof to treat hypercholesterolemia
EP2845591A1 (en) 2013-09-04 2015-03-11 Polichem S.A. Use of trifluoroacetic acid as keratolytic agent to treat hyperkeratotic skin lesions
KR101683635B1 (ko) 2014-12-29 2016-12-09 가천대학교 산학협력단 락테이트 금속염을 포함하는 암 치료용 약학 조성물
US10751365B2 (en) 2018-01-12 2020-08-25 Metimedi Pharmaceuticals Co., Ltd. Methods of treating chronic inflammatory diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4636564A (en) * 1984-11-13 1987-01-13 Board Of Trustees Of The University Of Alabama 5-cyanopyridine-2-diazohydroxide, basic salts and methods for production and use
US4880660A (en) * 1987-08-28 1989-11-14 Minnesota Mining And Manufacturing Company Method for priming hard tissue
US5250545A (en) * 1988-02-12 1993-10-05 Meiji Seika Kaisha, Ltd. Cancer cell metastasis inhibitor methods
UA32427C2 (uk) * 1993-10-15 2000-12-15 Елі Ліллі Енд Компані Застосування бензотіофенів або їх фармацевтично прийнятних солей або сольватів для інгібування ангіогенезу і/або ангіогенних захворювань
US5593987A (en) * 1993-12-21 1997-01-14 Eli Lilly And Company Methods of inhibiting breast disorders
US5639787A (en) * 1995-02-28 1997-06-17 The Center For The Improvement Of Human Functioning Int'l, Inc. Therapeutic method for the treatment of cancer

Also Published As

Publication number Publication date
EP1423131B1 (en) 2006-11-22
ITMI20011495A1 (it) 2003-01-12
WO2003006031A1 (en) 2003-01-23
EP1423131A1 (en) 2004-06-02
ES2277620T3 (es) 2007-07-16
US7423063B2 (en) 2008-09-09
CA2455710A1 (en) 2003-01-23
US20040180956A1 (en) 2004-09-16
CA2455710C (en) 2012-08-28
ITMI20011495A0 (it) 2001-07-12
DE60216292D1 (de) 2007-01-04
DE60216292T2 (de) 2007-08-30
JP4395368B2 (ja) 2010-01-06
ATE345805T1 (de) 2006-12-15
IL159770A (en) 2009-09-22
JP2004536120A (ja) 2004-12-02

Similar Documents

Publication Publication Date Title
HK1046093A1 (en) Docetaxel in combination with rhumab her2 for the treatment of cancers.
WO2004062604A3 (en) Treatment of cancer with 2-deoxyglucose
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
MY113059A (en) Controlled-release dosage forms of azithromycin
HRP20080598T3 (en) Combination of et-743 with 5-fluorouracil pro-drugs for the treatment of cancer
IL155781A0 (en) Effective antitumor treatments
TW200630089A (en) Treatment methods
MY164077A (en) Compositions and uses of et743 for treating cancer
BR0213906A (pt) Métodos para a produção de um efeito anti-angiogênico e ou redutor da permeabilidade vascular em um animal de sangue quente, e para o tratamento de um câncer em um animal de sangue quente, composição farmacêutica, kit, e, uso de zd6474 ou um seu sal farmaceuticamente aceitável e um taxano
BR0313117A (pt) Método para a produção de um efeito redutor de permeabilidade vascular e/ou antiangiogênico em um animal de sangue quente tal como um humano, método para o tratamento de um câncer em um animal de sangue quente tal como um humano, composição farmacêutica, kit, e, uso de zd6474 ou de um seu sal farmaceuticamente aceitável e de zd1839 ou de um seu sal farmaceuticamente aceitável
HK1047707A1 (zh) (+)-曲馬朵、o-去甲曲馬朵或(+)-o-去甲曲馬朵、o-去甲-n-單-去甲-曲馬朵或(+)-o-去甲-n-單-去甲-曲馬朵治療尿失禁的用途
CA2534577A1 (en) Method for promoting bone growth
GB0020504D0 (en) Therapeutic method
IL159770A0 (en) Calcium salts with cytotoxic activity
DE60222383D1 (de) Medikament zur verabreichung von amifostin und verwandten wirkstoffen
AU2001236529A1 (en) Combination therapy for cancer
IL151627A0 (en) Divided dose therapies with vascular damaging activity
EP1374873B8 (en) The use of n-acetyl-d-glucosamine in the manufacture of pharmaceutical useful for supressing side-effect of radiotherapy and chemotherapy
AU2003229876A1 (en) Tumour associated antigens
IL157408A (en) Use of elemental calcium in the manufacture of a medicament to reduce prostate cancer risk
WO2003059334A3 (en) Gemcitabine in the treatment of smallpox
UA33715A (uk) Спосіб лікування залізодефіцитних анемій у вагітних
UA36490A (uk) Спосіб лікування гнійно-септичних захворювань м'яких тканин
UA36756A (uk) Спосіб лікування хворих із злоякісними пухлинами молочної залози
BRPI0407301A (pt) Uso de uma combinação, composição farmacêutica, kit, e, método para o tratamento de câncer em um animal de sangue quente tal como um ser humano